Related Experiment Video
Updated: Jun 16, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Do antipsychotics limit disability in schizophrenia? A naturalistic comparative study in the community
Jagadisha Thirthalli1, Basappa K Venkatesh, Magadi N Naveen
1Department of Psychiatry, National Institute of Mental Health And Neurosciences (NIMHANS), Bangalore, India.
Indian Journal of Psychiatry
|February 23, 2010
Summary
Continuous antipsychotic treatment significantly reduces disability in schizophrenia patients compared to intermittent or no treatment. This highlights the critical importance of consistent antipsychotic medication for managing schizophrenia and improving patient outcomes.
Area of Science:
- Psychiatry
- Clinical Psychology
- Public Health
Background:
- Antipsychotics are established treatments for schizophrenia symptoms and relapse prevention.
- Comparative studies on the impact of antipsychotics on disability are limited.
- Understanding treatment effects on disability is crucial for comprehensive schizophrenia care.
Purpose of the Study:
- To compare disability levels in schizophrenia patients receiving continuous versus irregular/no antipsychotic treatment.
- To investigate the association between antipsychotic treatment status and disability in a rural community.
- To utilize a naturalistic comparative study design for real-world insights.
Main Methods:
- A comparative study involving 182 schizophrenia patients in rural Karnataka, India.
- Disability assessed using the Indian Disability Evaluation and Assessment Scale (IDEAS).
- Patients categorized based on continuous (n=50) versus irregular/off-antipsychotic (n=132) treatment over two years.
Main Results:
- Patients on continuous antipsychotic treatment demonstrated significantly lower disability scores across all domains and total scores.
- Multivariate regression confirmed treatment status as a significant predictor of disability, independent of confounders.
- A dose-response relationship was observed, with greater antipsychotic exposure correlating with reduced disability.
Conclusions:
- Consistent antipsychotic treatment is strongly associated with reduced disability in schizophrenia.
- There is a critical need to ensure all schizophrenia patients have access to and adhere to regular treatment.
- Optimizing antipsychotic treatment adherence can substantially improve functional outcomes in schizophrenia.
Related Concept Videos
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...